SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

被引:0
|
作者
Constanze Schneider
Thomas Oellerich
Hanna-Mari Baldauf
Sarah-Marie Schwarz
Dominique Thomas
Robert Flick
Hanibal Bohnenberger
Lars Kaderali
Lena Stegmann
Anjali Cremer
Margarethe Martin
Julian Lohmeyer
Martin Michaelis
Veit Hornung
Christoph Schliemann
Wolfgang E Berdel
Wolfgang Hartmann
Eva Wardelmann
Federico Comoglio
Martin-Leo Hansmann
Alexander F Yakunin
Gerd Geisslinger
Philipp Ströbel
Nerea Ferreirós
Hubert Serve
Oliver T Keppler
Jindrich Cinatl
机构
[1] Institute of Medical Virology,Department of Medicine II
[2] University of Frankfurt,Cambridge University Department of Haematology
[3] Hematology and Oncology,Department of Virology
[4] ,Department of Chemical Engineering and Applied Chemistry
[5] Goethe University of Frankfurt,Gene Center and Department of Biochemistry
[6] Cambridge Institute of Medical Research,Department of Medicine A (Hematology
[7] German Cancer Consortium partner site,undefined
[8] German Cancer Research Center,undefined
[9] Max von Pettenkofer Institute,undefined
[10] Ludwig Maximilian University of Munich,undefined
[11] Pharmazentrum frankfurt/ZAFES,undefined
[12] ,undefined
[13] Institute of Clinical Pharmacology,undefined
[14] Goethe University of Frankfurt,undefined
[15] University of Toronto,undefined
[16] Institute of Pathology,undefined
[17] University Medical Center,undefined
[18] Institute of Bioinformatics,undefined
[19] University Medicine Greifswald,undefined
[20] Centre for Molecular Processing and School of Biosciences,undefined
[21] University of Kent,undefined
[22] Institute of Molecular Medicine,undefined
[23] University Hospital Bonn,undefined
[24] Ludwig Maximilian University of Munich,undefined
[25] Oncology),undefined
[26] University Hospital Münster,undefined
[27] Gerhard Domagk Institute for Pathology,undefined
[28] University Hospital Münster,undefined
[29] Senckenberg Institute of Pathology,undefined
[30] University of Frankfurt,undefined
[31] Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),undefined
[32] Project Group Translational Medicine and Pharmacology (TMP),undefined
来源
Nature Medicine | 2017年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The therapeutic response of acute myeloid leukemia to the nucleoside analog Ara-C is controlled by SAMHD1, an enzyme that hydrolyzes the active metabolite Ara-CTP.
引用
收藏
页码:250 / 255
页数:5
相关论文
共 50 条
  • [31] PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
    Pandolfi, Ashley
    Stanley, Robert F.
    Yu, Yiting
    Bartholdy, Boris
    Pendurti, Gopichand
    Gritsman, Kira
    Boultwood, Jacqueline
    Chernoff, Jonathan
    Verma, Amit
    Steidl, Ulrich
    BLOOD, 2015, 126 (09) : 1118 - 1127
  • [32] PAK1 Is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Stanley, Robert
    Pandolfi, Ashley
    Verma, Amit
    Steidl, Ulrich
    Chernoff, Jonathan
    Yu, Yiting
    Boultwood, Jacqueline
    BLOOD, 2014, 124 (21)
  • [33] PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
    Kontandreopoulou, Christina-Nefeli
    Diamantopoulos, Panagiotis T.
    Tiblalexi, Despina
    Giannakopoulou, Nefeli
    Viniou, Nora-Athina
    BLOOD ADVANCES, 2021, 5 (22) : 4794 - 4805
  • [34] PIVOTAL BIOMARKER ALTERATIONS IN CYTARABINE-RESISTANT ACUTE MYELOID LEUKEMIA CELL LINES
    Lin, L. I.
    Lu, J. W.
    Lim, P. P.
    Lai, Y. L.
    Chen, C. Y.
    Tien, H. F.
    HAEMATOLOGICA, 2015, 100 : 364 - 365
  • [35] SAMHD1: a restriction factor in the replication of HIV-1 in myeloid cells
    Guenzel, Caroline A.
    Benichou, Serge
    VIROLOGIE, 2011, 15 (05) : 338 - 340
  • [36] SAMHD1: a new insight into HIV-1 restriction in myeloid cells
    Corine St Gelais
    Li Wu
    Retrovirology, 8
  • [37] SAMHD1: a new insight into HIV-1 restriction in myeloid cells
    St Gelais, Corine
    Wu, Li
    RETROVIROLOGY, 2011, 8
  • [38] Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia
    Yao, Yunying
    Xia, Zhizhou
    Wu, Min
    Jiao, Bo
    Gao, Jiaming
    Li, Donghe
    Xie, Xi
    Xu, Pengfei
    Li, Jiaoyang
    Yan, Lei
    Ren, Ruibao
    Liu, Ping
    GENES & DISEASES, 2024, 11 (04)
  • [39] Cytarabine Dose for Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2168 - 2169
  • [40] Cytarabine and skin reactions in acute myeloid leukemia
    Grille, Sofia
    Guadagna, Regina
    Boada, Matilde
    Irigoin, Victoria
    Stevenazzi, Mariana
    Guillermo, Cecilia
    Diaz, Lilian
    MEDICINA-BUENOS AIRES, 2013, 73 (06) : 535 - 538